BACKGROUND End-Stage renal disease (ESRD) causes considerable morbidity and mortality, and significantly alters patients' quality of life. There are very few published data on this problem in the French Overseas territories. The development of a registry on end stage renal disease in French Guiana in 2011 allowed to describe the magnitude of this problem in the region for the first time. METH...

This article presents a detailed account of the incidence, prevalence, and survival experience of people with end-stage renal disease (ESRD) covered by Medicare. The number of new entrants into the ESRD program has risen since its inception. This increase is greatest for people whose cause of renal failure is primary hypertensive disease or diabetic nephropathy. The program incidence rates for ...

one of the most striking features in autosomal dominant polycystic kidney disease (adpkd) is the difference at onset age of end-stage renal disease (esrd). modifier genes may play a role in this phenotypic variability. the mutated nitric oxide synthase 3 gene (nos3), have a modifier effect on the severity of adpkd by impairment of nos3 activity and decreasing of renal vascular nitric oxide prod...

A synopsis is given between the relationship of the number of end stage renal disease (ESRD) patients to the total Medicare population and their associated expenditures. The aging trend within the ESRD population is examined in terms of enrollment statistics and incidence (new cases) counts. Also, longitudinal trends in expenditures, program enrollment, and incidence of ESRD are included. Findi...

More than half of 174 patients with end stage renal disease (ESRD) treated by the Department of Nephrology, General Hospital Kuala Lumpur in 1982 presented for the first time in uraemia, with no known renal disease in the past. Although about half of all patients seen in 1982 were treated by dialysis or transplantation, the great majority of the estimated number of patients developing ESRD in M...

The SARS-CoV-2 pandemic has been associated with a drop in diagnoses of several diseases 2020, including cancers. In this letter addressed to the editor, Groupement des Néphrologues Francophones de Belgique (GNFB), assessed whether there was similar effect concerning end-stage renal disease (ESRD).
 Data patients ESRD form 25 26 centers constituting GNFB register were collected. conclusion...

UNLABELLED Chronic kidney disease (CKD) and end-stage renal disease (ESRD) have emerged as a worldwide public health problem. Due to the remarkably higher incidence and prevalence of this chronic disease in Taiwan than in other countries, CKD/ESRD has contributed to a significant health burden in Taiwan. Patients with CKD/ESRD have an increased risk of coronary artery disease (CAD) and acute co...

INTRODUCTION Cardiovascular disease is the leading cause of death in patients with end stage renal disease (ESRD). The vasodilator mechanisms in small resistance arteries are in earlier studies shown to be reduced in patients with end stage renal disease. We studied whether endothelium dependent vasodilatation were diminished in ESRD patients and the interaction between the macro- and microcirc...

BACKGROUND Maintenance hemodialysis is a popular treatment modality of renal replacement therapy for end stage disease patients. The clinical profile end-stage (ESRD) and dialysis in Mid Western Nepal are scarce. This study aimed to the ESRD patients undergoing at tertiary care Hospital.
 METHODS was single center based cross sectional observational carried out over period from 15th Decemb...